Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase
about
Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signalingThe p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complexFBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascadeThe PTEN/PI3K pathway governs normal vascular development and tumor angiogenesisA pharmacological map of the PI3-K family defines a role for p110alpha in insulin signalingThe PI3K pathway as drug target in human cancerInsulin receptor signaling in normal and insulin-resistant statesPhosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola VirusThe p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis.Essential role for the p110delta phosphoinositide 3-kinase in the allergic responseNegative regulators of insulin signaling revealed in a genome-wide functional screenPositive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signalingp85alpha acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiationp85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB responseDirect positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangementA PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis.Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice.Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation.Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinaseMetabolic syndrome and insulin resistance: underlying causes and modification by exercise training.Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta-/- miceIrs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growthImpairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity.p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance.Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance.Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.Dicer-1-dependent Dacapo suppression acts downstream of Insulin receptor in regulating cell division of Drosophila germline stem cellsLipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models.BMP2-induced chemotaxis requires PI3K p55γ/p110α-dependent phosphatidylinositol (3,4,5)-triphosphate production and LL5β recruitment at the cytocortexThe phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alphaSite and mechanism of leptin action in a rodent form of congenital lipodystrophyClass IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
P2860
Q24302191-C2F141BD-5C24-419D-A0E2-AB26F5C95681Q24310123-1E1CBF1A-BBD3-4BDB-AC08-4AFDE4618F8CQ24338848-55FE5CD6-A5FB-41DF-8F4C-EA9512689258Q24531835-2C59AB4B-192E-4CE8-A0CA-A176CF9BD8B0Q24599676-9B32916D-AA81-4F1A-9CBC-23222572F562Q24632283-44AB4C3C-AC5B-4B94-9D77-5C016C40E609Q26823171-911E6FE2-2DD1-4ADE-83C4-A9831D43FBBFQ27486638-78CD4B81-953F-44B3-BC62-75F11A96B113Q27851848-BA823BD9-909A-4070-A573-13D483E8F97FQ28288981-6D055841-37AA-4814-9FE1-BCE97517168FQ28476047-FD6B9E77-F1EF-4A1E-9A73-DF30BFD2A03DQ28506865-7C8CD5D4-656C-4AF8-B726-40001AFD53F1Q28513416-297F80F4-A668-49A1-8EB9-0453E80A70E4Q28590571-895855EC-2A8F-48E1-A123-567F3BCAE5FEQ30156937-63BE3DA9-136D-4516-8FA7-AAECECC62131Q30160287-940A1D73-A6D4-4A3E-9D52-27A1005ADF82Q30478155-BA13584A-F9E1-4DE5-A5ED-377EB392C1A0Q30481572-266CB95F-7BC4-4338-9303-08A8A50C9FE1Q30494377-7C52C812-B1C0-441B-B17F-5B7FC3E7D141Q33680436-6C46E313-09F9-433A-A611-B076E5C03772Q33860786-E156EE67-B8CA-4E1F-975D-BFBC37224E1FQ33895741-5E4FDFB7-7453-4071-9F36-1B755950F8FCQ34031701-9179EF73-8D0A-4122-B000-1445178D63B4Q34097448-3F530FD2-8AC2-4C87-91DD-AAB1B8F6127DQ34182057-596F6B9E-5417-40B4-B2C0-27588E09DA45Q34236816-AEE5E93F-8A0A-4C61-82D9-71D278B63959Q34375659-727BE1C8-6D61-4E2D-BC7B-43322731F894Q34550411-83D9BBF5-EE31-4690-A434-D54278E32E31Q34722653-B897D6A0-948D-42CE-B041-9B6581BE4155Q34804886-F8646528-4055-46C3-9A43-0DBC2BB71BEDQ34882666-872C57A7-3901-4E57-99BA-080B8D37CB87Q34972215-33C0D9F2-AFE1-4593-95AC-76C1BD9DA6BEQ35096682-7CC9BCD5-8237-4DDE-A19F-C2F21B2676F3Q35113376-8A9389DD-326F-4D0D-8FD9-74DE748FD2DFQ35128706-D59B2902-588B-4381-A7FA-BB46B280285FQ35178694-EFDC38AB-EAA8-418D-998F-8A208F716066Q35479152-E6E5F19D-F329-48FB-B66C-CB7A3D4C56A8Q35487650-AD026762-ECF5-42E4-92C9-E284F9361BEAQ35631912-E3862382-6B16-4FDD-B5B3-83930F2F341BQ35808718-071CF444-4B6D-43A2-B772-B5D0E0E4A1C3
P2860
Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@ast
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en-gb
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@nl
type
label
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@ast
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en-gb
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@nl
prefLabel
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@ast
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en-gb
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@nl
P2093
P2860
P50
P3181
P356
P1476
Increased insulin sensitivity ...... t of phosphoinositide 3-kinase
@en
P2093
Claudine M Yballe
David Vicent
John M Watt
Saskia M Brachmann
P2860
P304
P3181
P356
10.1073/PNAS.012581799
P407
P577
2002-01-08T00:00:00Z